FrancophonIA/ELRC3.0 huggingface dataset:
English: Tell your doctor if you have or have had or develop any medical conditions or symptoms, especially any of the following: - Kidney disease - Hallucinations (seeing, hearing or feeling things that are not there).
Croatian: Obavijestite svog liječnika ako imate ili ste imali ili Vam se pojavilo bilo koje medicinsko stanje ili simptomi, osobito sljedeće: Bolest bubrega
English: The daily dose should not exceed 6 tablets Oprymea 0.088 mg or a dose of 0.54 mg (0.75 mg pramipexole salt).
Croatian: Oprymea 0,088 mg ili dozu od 0,54 mg (0,75 mg soli pramipeksola).
English: - 7 prolonged-release tablets of 0.52 mg
Croatian: 7 tableta s produljenim oslobađanjem od 0,52 mg
English: Doses should be increased gradually from a starting dose of 0.26 mg of base (0.375 mg of salt) per day and then increased every 5 - 7 days.
Croatian: Dozu je potrebno postupno povisivati od početne doze 0,26 mg baze (0,375 mg soli) dnevno, svakih 5-7 dana.
English: Oprymea 0.088 mg tablets White, round, with bevelled edges and imprint "P6" on one side of the tablet.
Croatian: Oprymea 0,088 mg tablete Bijela, okrugla, ukošenih rubova i s utisnutom oznakom "P6" na jednoj strani tablete.
English: One Oprymea 0.52 mg prolonged-release tablet on blister "Week 2".
Croatian: Jedna Oprymea 0,52 mg tableta s produljenim oslobađanjem iz blistera "2. tjedan".
English: Pramipexole is completely absorbed following oral administration.
Croatian: Pramipeksol se u potpunosti apsorbira nakon peroralne primjene.
English: However, it should be noted that the incidence of somnolence is increased at doses higher than 1.5 mg (of salt) per day (see section 4.8).
Croatian: Međutim, potrebno je napomenuti da se incidencija somnolencije povećava pri dozama višim od 1,5 mg dnevno (vidjeti dio 4.8).
English: The individual dose of pramipexole should be in the range of 0.264 mg of base (0.375 mg of salt) to a maximum of 3.3 mg of base (4.5 mg of salt) per day.
Croatian: Individualna doza pramipeksola mora biti u rasponu od 0,264 mg baze (0,375 mg soli) do maksimalno 3,3 mg baze (4,5 mg soli) dnevno.
English: 1 tablet Oprymea 0.088 mg three times a day
Croatian: 1 tableta Oprymea 0,088 mg tri puta dnevno
English: Oprymea 0.35 mg tablets
Croatian: Oprymea 0,35 mg tablete
English: Doses should be increased gradually from a starting-dose of 0.264 mg of base (0.375 mg of salt) per day and then increased every 5 - 7 days.
Croatian: Dozu je potrebno postupno povisivati od početne doze 0,264 mg baze (0,375 mg soli) dnevno, svakih 5-7 dana.
English: If a further dose increase is necessary the daily dose should be increased by 0.52 mg of base (0.75 mg of salt) at weekly intervals up to a maximum dose of 3.15 mg of base (4.5 mg of salt) per day.
Croatian: U slučaju potrebe za dodatnim povišenjem doze, dnevna se doza treba povisiti za 0,52 mg baze (0,75 mg soli) u tjednim intervalima, sve do maksimalne dnevne doze od 3,15 mg baze (4,5 mg soli).
English: Each prolonged-release tablet contains 0.26 mg, 0.52 mg or 1.05 mg pramipexole as 0.375 mg, 0.75 mg or 1.5 mg pramipexole dihydrochloride monohydrate, respectively.
Croatian: Jedna tableta s produljenim oslobađanjem sadrži 0,26 mg, 0,52 mg ili 1,05 mg pramipeksola u obliku 0,375 mg, 0,75 mg odnosno 1,5 mg pramipeksoldiklorid hidrata.
English: If a further dose increase is necessary the daily dose should be increased by 0.54 mg of base (0.75 mg of salt) at weekly intervals up to a maximum dose of 3.3 mg of base (4.5 mg of salt) per day.
Croatian: U slučaju potrebe za dodatnim povišenjem doze, dnevna se doza treba povisiti za 0,54 mg baze (0,75 mg soli) u tjednim intervalima, sve do maksimalne dnevne doze od 3,3 mg baze (4,5 mg soli).
English: Oprymea 0.18 mg tablets
Croatian: Oprymea 0,18 mg tablete
English: The individual dose of pramipexole should be in the range of 0.26 mg of base (0.375 mg of salt) to a maximum of 3.15 mg of base (4.5 mg of salt) per day.
Croatian: Individualna doza pramipeksola mora biti u rasponu od 0,26 mg baze (0,375 mg soli) do maksimalno 3,15 mg baze (4,5 mg soli) dnevno.
English: 6.3 Shelf life
Croatian: 6.3 Rokvaljanosti
English: One Oprymea 0.52 mg prolonged-release tablet, OR two Oprymea 0.26 mg prolonged-release tablets.
Croatian: Jedna Oprymea 0,52 mg tableta s produljenim oslobađanjem ILI dvije Oprymea 0,26 mg tablete s produljenim oslobađanjem
English: Restless Legs Syndrome, most common adverse reactions The most commonly (≥ 5%) reported adverse drug reactions in patients with Restless Legs Syndrome treated with pramipexole were nausea, headache, dizziness and fatigue.
Croatian: Najčešće (≥ 5%) prijavljene nuspojave u bolesnika sa sindromom nemirnih nogu, u liječenju pramipeksolom bile su mučnina, glavobolja, omaglica i umor.
English: During the first week, the usual dose is 1 tablet Oprymea 0.088 mg once a day (equivalent to 0.088 mg daily):
Croatian: Oprymea 0,088 mg jedanput dnevno (što odgovara 0,088 mg dnevno):
English: Oprymea 0.088 mg tablets Pramipexole
Croatian: Oprymea 0,088 mg tablete pramipeksol
English: Oprymea 1.1 mg tablets Pramipexole
Croatian: Oprymea 1,1 mg tablete pramipeksol
English: 1 tablet Oprymea 0.18 mg three times a day OR
Croatian: 1 tableta Oprymea 0,18 mg tri puta dnevno ILI
English: Common may affect up to 1 in 10 people
Croatian: mogu se javiti u do 1 na 10 osoba
English: Daily dose (mg of salt)
Croatian: Dnevna doza (mg soli)
English: Oprymea 0.088 mg tablets Each tablet contains 0.088 mg pramipexole (as 0.125 mg pramipexole dihydrochloride monohydrate).
Croatian: Oprymea 0,088 mg tablete Jedna tableta sadrži 0,088 mg pramipeksola (u obliku 0,125 mg pramipeksoldiklorid hidrat).
English: Patients and carers should be made aware that behavioural symptoms of impulse control disorders including pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists including Oprymea.
Croatian: Bolesnici i njihovi njegovatelji moraju biti svjesni simptoma poremećaja kontrole nagona uključujući patološku želju za kockanjem, pojačani libido, hiperseksualnost, kompulzivno trošenje ili kupovanje, prejedanje i kompulzivno jedenje koji se mogu javiti u bolesnika liječenih dopaminskim agonistima uključujući lijek Oprymea.
English: 3 tablets Oprymea 0.18 mg OR
Croatian: 3 tablete Oprymea 0,18 mg ILI
English: Psychiatric disorders insomnia abnormal dreams restlessness confusion hallucinations libido disorder delusion hyperphagia paranoia mania delirium behavioural symptoms of impulse control disorders and compulsions (such as: compulsive shopping, pathological gambling, hypersexuality, binge eating)
Croatian: Psihijatrijski poremećaji nesanica abnormalni snovi nemir smetenost halucinacije poremećaj libida sumanutost hiperfagija paranoja manija delirij bihevioralni simptomi u vidu poremećaja kontrole nagona i kompulzije
English: Oprymea 0.7 mg tablets
Croatian: Oprymea 0,7 mg tablete
English: In advanced Parkinson's disease, in combination treatment with levodopa, dyskinesia can occur during the initial titration of Oprymea.
Croatian: Tijekom početne titracije lijeka Oprymea kod uznapredovale Parkinsonove bolesti, može doći do pojava diskinezije u bolesnika liječenih kombinacijom pramipeksola i levodope.
English: Oprymea 0.26 mg prolonged-release tablets Oprymea 0.52 mg prolonged-release tablets Oprymea 1.05 mg prolonged-release tablets Oprymea 1.57 mg prolonged-release tablets Oprymea 2.1 mg prolonged-release tablets Oprymea 2.62 mg prolonged-release tablets Oprymea 3.15 mg prolonged-release tablets
Croatian: Oprymea 0,26 mg tablete s produljenim oslobađanjem Oprymea 0,52 mg tablete s produljenim oslobađanjem Oprymea 1,05 mg tablete s produljenim oslobađanjem Oprymea 1,57 mg tablete s produljenim oslobađanjem Oprymea 2,1 mg tablete s produljenim oslobađanjem Oprymea 2,62 mg tablete s produljenim oslobađanjem Oprymea 3,15 mg tablete s produljenim oslobađanjem pramipeksol
English: Oprymea 0.35 mg tablets are white, oval, with bevelled edges, both sides scored, with imprint "P8" on both halves of one side of the tablet.
Croatian: Oprymea 0,35 mg tablete su bijele, ovalne, ukošenih rubova, s razdjelnom crtom na obje strane i s utisnutom oznakom "P8" na obje polovice jedne strane tablete.
English: Oprymea 1.1 mg tablets Each tablet contains 1.1 mg pramipexole (as 1.5 mg pramipexole dihydrochloride monohydrate).
Croatian: Oprymea 1,1 mg tablete Jedna tableta sadrži 1,1 mg pramipeksola (u obliku 1,5 mg pramipeksoldiklorid hidrat).
English: IJ
Croatian: C.
English: Pramipexole should be tapered off at a rate of 0.52 mg of base (0.75 mg of salt) per day until the daily dose has been reduced to 0.52 mg of base (0.75 mg of salt).
Croatian: Stoga je potrebno postupno smanjivati dozu pramipeksola za 0,52 mg baze (0,75 mg soli) dnevno, sve dok se ukupna dnevna doza ne snizi na 0,52 mg baze (0,75 mg soli).
English: Patients and carers should be made aware that behavioural symptoms of impulse control disorders including pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists including pramipexole.
Croatian: Bolesnici i njihovi njegovatelji moraju biti svjesni simptoma poremećaja kontrole nagona uključujući patološku želju za kockanjem, pojačani libido, hiperseksualnost, kompulzivno trošenje ili kupovanje, prejedanje i kompulzivno jedenje koji se mogu javiti u bolesnika liječenih dopaminskim agonistima uključujući pramipeksol.
English: Oprymea 0.35 mg tablets Each tablet contains 0.35 mg pramipexole (as 0.5 mg pramipexole dihydrochloride monohydrate).
Croatian: Oprymea 0,35 mg tablete Jedna tableta sadrži 0,35 mg pramipeksola (u obliku 0,5 mg pramipeksoldiklorid hidrat).
English: 1 tablet Oprymea 0.18 mg OR
Croatian: 1 tableta Oprymea 0,18 mg ILI
English: Furthermore a reduction of the dose or termination of therapy may be considered.
Croatian: U takvih bolesnika treba se razmisliti o sniženju doze ili prekidu liječenja.
English: 7 tablets of Oprymea 0.52 mg
Croatian: 7 Oprymea 0,52 mg tableta
English: Oprymea 0.18 mg tablets are white, oval, with bevelled edges, both sides scored, with imprint "P7" on both halves of one side of the tablet.
Croatian: Oprymea 0,18 mg tablete su bijele, ovalne, ukošenih rubova, s razdjelnom crtom na obje strane i s utisnutom oznakom "P7" na obje polovice jedne strane tablete.
English: Ascending - Dose Schedule of Oprymea Week
Croatian: Postupak povećanja doze lijeka Oprymea Tjedan
English: Oprymea 2.62 mg prolonged-release tablets
Croatian: Oprymea 2,62 mg tablete s produljenim oslobađanjem
English: Oprymea 0.70 mg tablets are white, round, with bevelled edges, both sides scored, with imprint "P9" on both halves of one side of the tablet.
Croatian: Oprymea 0,70 mg tablete su bijele, okrugle, ukošenih rubova, s razdjelnom crtom na obje strane i s utisnutom oznakom "P9" na obje polovice jedne strane tablete.
English: Oprymea 0.18 mg tablets Each tablet contains 0.18 mg pramipexole (as 0.25 mg pramipexole dihydrochloride monohydrate).
Croatian: Oprymea 0,18 mg tablete Jedna tableta sadrži 0,18 mg pramipeksola (u obliku 0, 25 mg pramipeksoldiklorid hidrat).
English: Each prolonged-release tablet contains 2.62 mg pramipexole (as 3.75 mg pramipexole dihydrochloride monohydrate).
Croatian: Jedna tableta s produljenim oslobađanjem sadrži 2,62 mg pramipeksola (u obliku 3,75 mg pramipeksoldiklorid hidrat).
English: 1 tablet Oprymea 0.088 mg
Croatian: 1 tableta Oprymea 0,088 mg
English: Oprymea 1.05 mg: Each prolonged-release tablet contains 1.05 mg pramipexole (as 1.5 mg pramipexole dihydrochloride monohydrate).
Croatian: Oprymea 1,05 mg: Jedna tableta s produljenim oslobađanjem sadrži 1,05 mg pramipeksola (u obliku 1,5 mg pramipeksoldiklorid hidrat).
English: Not known: - After stopping or reducing your Oprymea treatment: Depression, apathy, anxiety, fatigue,
Croatian: Nepoznato: nakon prestanka liječenja ili sniženja doze lijeka Oprymea: mogu se javiti depresija, apatija, tjeskoba, umor, znojenje ili bol (što se naziva sindromom ustezanja od agonista dopamina).
English: Oprymea 3.15 mg prolonged-release tablets
Croatian: Oprymea 3,15 mg tablete s produljenim oslobađanjem
English: White, oval, with bevelled edges, both sides scored, with imprint "P7" on both halves of one side of the tablet.
Croatian: Bijela, ovalna, ukošenih rubova, s razdjelnim urezom na obje strane i s utisnutom oznakom "P7" na obje polovice jedne strane tablete.
English: OR
Croatian: I
English: White, oval, with bevelled edges, both sides scored, with imprint "P8" on both halves of one side of the tablet.
Croatian: Bijela, ovalna, ukošenih rubova, s razdjelnim urezom na obje strane i s utisnutom oznakom "P8" na obje polovice jedne strane tablete.
English: Each prolonged-release tablet contains 3.15 mg pramipexole (as 4.5 mg pramipexole dihydrochloride monohydrate).
Croatian: Jedna tableta s produljenim oslobađanjem sadrži 3,15 mg pramipeksola (u obliku 4,5 mg pramipeksoldiklorid hidrat).
English: Each tablet contains 0.088 mg pramipexole (as 0.125 mg pramipexole dihydrochloride monohydrate).
Croatian: Jedna tableta sadrži 0,088 mg pramipeksola (u obliku 0,125 mg pramipeksoldiklorid hidrat).
English: Oprymea 0.35 mg tablets Pramipexole
Croatian: Oprymea 0,35 mg tablete pramipeksol
English: Oprymea 0.52 mg prolonged-release tablets
Croatian: Oprymea 0,52 mg tablete s produljenim oslobađanjem
English: Focus Care Pharmaceuticals B.V. Tel: +31 (0)75 612 05 11
Croatian: Tel: +31 (0)75 612 05 11
English: White, round, with bevelled edges, both sides scored, with imprint "P9" on both halves of one side of the tablet.
Croatian: Bijela, okrugla, ukošenih rubova, s razdjelnim urezom na obje strane i s utisnutom oznakom "P9" na obje polovice jedne strane tablete.
English: If you get any side effects, talk to your doctor or pharmacist.
Croatian: Prije nego što počnete uzimati bilo koji lijek posavjetujte se sa svojim liječnikom ili ljekarnikom.
English: Oprymea 0.18 mg tablets Pramipexole
Croatian: Oprymea 0,18 mg tablete pramipeksol
English: 2 tablets Oprymea 0.088 mg
Croatian: 2 tablete Oprymea 0,088 mg
English: 2 tablets Oprymea 0.18 mg
Croatian: 2 tablete Oprymea 0,18 mg ILI
English: Each tablet contains 0.7 mg pramipexole (as 1 mg pramipexole dihydrochloride monohydrate).
Croatian: Jedna tableta sadrži 0,7 mg pramipeksola (u obliku 1 mg pramipeksoldiklorid hidrat).
English: Take your Oprymea (immediate release) tablets as normal the day before you switch.
Croatian: Uzmite Oprymea tablete (s trenutnim oslobađanjem) po uobičajenom rasporedu dan prije prijelaza na drugu terapiju.
English: Each prolonged-release tablet contains 2.1 mg pramipexole (as 3 mg pramipexole dihydrochloride monohydrate).
Croatian: Jedna tableta s produljenim oslobađanjem sadrži 2,1 mg pramipeksola (u obliku 3 mg pramipeksoldiklorid hidrat).
English: Oprymea 0.52 mg: Each prolonged-release tablet contains 0.52 mg pramipexole (as 0.75 mg pramipexole dihydrochloride monohydrate).
Croatian: Oprymea 0,52 mg: Jedna tableta s produljenim oslobađanjem sadrži 0,52 mg pramipeksola (u obliku 0,75 mg pramipeksoldiklorid hidrat).
English: 4 tablets Oprymea 0.088 mg
Croatian: 4 tablete Oprymea 0,088 mg
English: - Hallucinations (seeing, hearing or feeling things that are not there) - Confusion - Excessive daytime sleepiness and suddenly falling asleep - Weight increase - Hypotension (low blood pressure) - Excess of fluid, usually in the legs (peripheral oedema) - Allergic reactions (e.g. rash, itching, hypersensitivity) - Fainting - Restlessness - Visual impairment - Weight loss including decreased appetite - Dyspnoea (difficulties to breathe) - Hiccups - Pneumonia (infection of the lungs)* - Inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include:
Croatian: Manje često: potreba za neuobičajenim ponašanjem* zatajenje srca (problemi sa srcem koji mogu izazvati nedostatak zraka ili otečenost gležnjeva)* neodgovarajuće lučenje antidiuretskog hormona* diskinezija (npr. abnormalni, nekontrolirani pokreti udova) hiperkinezija (pojačani pokreti i nesposobnost ostajanja u mirnom položaju)* paranoja (npr. pretjerani strah za vlastitu dobrobit)* zablude (deluzije)* amnezija (poremećaj pamćenja)* halucinacije (vidjeti, čuti ili osjećati stvari koje nisu prisutne) smetenost prekomjerna dnevna pospanost i iznenadno usnivanje porast tjelesne težine hipotenzija (niski krvni tlak) prekomjerno nakupljanje tekućine, obično u nogama (periferni edem) alergijske reakcije (npr. osip, svrbež, preosjetljivost) nesvjestica nemir poremećaji vida gubitak težine uključujući smanjeni apetit zaduha (otežano disanje) štucanje upala pluća (infekcija pluća)* nemogućnost odupiranja nagonu, porivu ili iskušenju za vršenje radnji koje bi mogle naškoditi Vama ili drugima, što može uključivati:
English: Oprymea 0.26 mg prolonged-release tablets
Croatian: Oprymea 0,26 mg tablete s produljenim oslobađanjem
English: Oprymea 0.7 mg tablets Pramipexole
Croatian: Oprymea 0,7 mg tablete pramipeksol
English: Colloidal anhydrous silica Magnesium stearate
Croatian: 6.1 Popis pomoćnihtvari hipromeloza kukuruzni škrob silicijev dioksid, koloidni, bezvodni magnezijev stearat
English: Oprymea 3.15 mg prolonged-release tablets are white or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P5 on one side and 315 on the other side, with bevelled edges and possible spots.
Croatian: Oprymea 3,15 mg tablete s produljenim oslobađanjem su bijele ili gotovo bijele boje, okrugle (promjera 10 mm), blago bikonveksne tablete s utisnutom oznakom P5 na jednoj strani i 315 na drugoj strani, s ukošenim rubovima i mogućim točkicama.
English: Oprymea 1.57 mg prolonged-release tablets
Croatian: Oprymea 1,57 mg tablete s produljenim oslobađanjem
English: Oprymea 1.05 mg prolonged-release tablets
Croatian: Oprymea 1,05 mg tablete s produljenim oslobađanjem
English: The following dose schedule is suggested:
Croatian: Preporučuje se sljedeća shema doziranja u početku liječenja:
English: Ascending dose schedule of Oprymea prolonged-release tablets Week Daily dose (mg) Number of tablets
Croatian: Tjedan Dnevna doza (mg) Broj tableta
English: 6 tablets Oprymea 0.088 mg
Croatian: 6 tableta Oprymea 0,088 mg
English: Each tablet contains 1.1 mg pramipexole (as 1.5 mg pramipexole dihydrochloride monohydrate).
Croatian: Jedna tableta sadrži 1,1 mg pramipeksola (u obliku 1,5 mg pramipeksoldiklorid hidrat).
English: 0.26 mg: White or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P1 on one side, with bevelled edges and possible spots.
Croatian: 0,26 mg: Bijele ili gotovo bijele, okrugle (promjera 10 mm), blago bikonveksne tablete s utisnutom oznakom P1 na jednoj strani, s ukošenim rubovima i mogućim točkicama.
English: Each prolonged-release tablet contains 1.57 mg pramipexole (as 2.25 mg pramipexole dihydrochloride monohydrate).
Croatian: Jedna tableta s produljenim oslobađanjem sadrži 1,57 mg pramipeksola (u obliku 2,25 mg pramipeksoldiklorid hidrat).
English: Each tablet contains 0.18 mg pramipexole (as 0.25 mg pramipexole dihydrochloride monohydrate).
Croatian: Jedna tableta sadrži 0,18 mg pramipeksola (u obliku 0,25 mg pramipeksoldiklorid hidrat).
English: Each prolonged-release tablet contains 0.26 mg pramipexole (as 0.375 mg pramipexole dihydrochloride monohydrate).
Croatian: Jedna tableta s produljenim oslobađanjem sadrži 0,26 mg pramipeksola (u obliku 0,375 mg pramipeksoldiklorid hidrat).
English: Each prolonged-release tablet contains 1.05 mg pramipexole (as 1.5 mg pramipexole dihydrochloride monohydrate).
Croatian: Jedna tableta s produljenim oslobađanjem sadrži 1,05 mg pramipeksola (u obliku 1,5 mg pramipeksoldiklorid hidrat).
English: Each prolonged-release tablet contains 0.52 mg pramipexole (as 0.75 mg pramipexole dihydrochloride monohydrate).
Croatian: Jedna tableta s produljenim oslobađanjem sadrži 0,52 mg pramipeksola (u obliku 0,75 mg pramipeksoldiklorid hidrat).
English: Oprymea 0.35 mg tablets 20 tablets: EU/1/08/469/011 30 tablets: EU/1/08/469/012 60 tablets: EU/1/08/469/013 90 tablets: EU/1/08/469/014 100 tablets: EU/1/08/469/015
Croatian: Oprymea 0,35 mg tablete 20 tableta: EU/1/08/469/011 30 tableta: EU/1/08/469/012 60 tableta: EU/1/08/469/013 90 tableta: EU/1/08/469/014 100 tableta: EU/1/08/469/015
English: 1.05 mg: White or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P3 on one side, with bevelled edges and possible spots.
Croatian: 1,05 mg: Bijele ili gotovo bijele, okrugle (promjera 10 mm), blago bikonveksne tablete s utisnutom oznakom P3 na jednoj strani, s ukošenim rubovima i mogućim točkicama.
English: Oprymea 1.1 mg tablets 20 tablets: EU/1/08/469/021 30 tablets: EU/1/08/469/022 60 tablets: EU/1/08/469/023 90 tablets: EU/1/08/469/024 100 tablets: EU/1/08/469/025
Croatian: Oprymea 1,1 mg tablete 20 tableta: EU/1/08/469/021 30 tableta: EU/1/08/469/022 60 tableta: EU/1/08/469/023 90 tableta: EU/1/08/469/024 100 tableta: EU/1/08/469/025
English: Each tablet contains 0.35 mg pramipexole (as 0.5 mg pramipexole dihydrochloride monohydrate).
Croatian: Jedna tableta sadrži 0,35 mg pramipeksola (u obliku 0,5 mg pramipeksoldiklorid hidrat).
English: Oprymea 0.26 mg: Each prolonged-release tablet contains 0.26 mg pramipexole (as 0.375 mg pramipexole dihydrochloride monohydrate).
Croatian: Oprymea 0,26 mg: Jedna tableta s produljenim oslobađanjem sadrži 0,26 mg pramipeksola (u obliku 0,375 mg pramipeksoldiklorid hidrat).
English: (mg of base)
Croatian: (mg)
English: 1 tablet Oprymea 0.35 mg and 1 tablet Oprymea 0.18 mg
Croatian: 1 tableta Oprymea 0,35 mg i 1 tableta
English: Oprymea 2.62 mg prolonged-release tablets Pramipexole
Croatian: Oprymea 2,62 mg tablete s produljenim oslobađanjem pramipeksol
English: MARKETING AUTHORISATION NUMBER(S)
Croatian: Poluvrijeme eliminacije (t
English: 60 tablets: EU/1/08/469/003 90 tablets: EU/1/08/469/004 100 tablets: EU/1/08/469/005
Croatian: 20 tableta: EU/1/08/469/001 30 tableta: EU/1/08/469/002 60 tableta: EU/1/08/469/003 90 tableta: EU/1/08/469/004 100 tableta: EU/1/08/469/005
English: Oprymea 3.15 mg prolonged-release tablets Pramipexole
Croatian: Oprymea 3,15 mg tablete s produljenim oslobađanjem pramipeksol
English: Oprymea 0.18 mg tablets 20 tablets: EU/1/08/469/006 30 tablets: EU/1/08/469/007 60 tablets: EU/1/08/469/008 90 tablets: EU/1/08/469/009 100 tablets: EU/1/08/469/010
Croatian: Oprymea 0,18 mg tablete 20 tableta: EU/1/08/469/006 30 tableta: EU/1/08/469/007 60 tableta: EU/1/08/469/008 90 tableta: EU/1/08/469/009 100 tableta: EU/1/08/469/010
English: Oprymea 2.1 mg prolonged-release tablets
Croatian: Oprymea 2,1 mg tablete s produljenim oslobađanjem
English: Uncommon may affect up to 1 in 100 people
Croatian: Manje često mogu se javiti u do 1 na 100 osoba
English: Oprymea 0.26 mg prolonged-release tablets Oprymea 0.52 mg prolonged-release tablets Oprymea 1.05 mg prolonged-release tablets
Croatian: Oprymea 0,26 mg tablete s produljenim oslobađanjem Oprymea 0,52 mg tablete s produljenim oslobađanjem Oprymea 1,05 mg tablete s produljenim oslobađanjem
English: EU/1/08/469/011 [20 tablets] EU/1/08/469/012 [30 tablets] EU/1/08/469/013 [60 tablets] EU/1/08/469/014 [90 tablets] EU/1/08/469/015 [100 tablets]
Croatian: EU/1/08/469/011 [20 tableta] EU/1/08/469/012 [30 tableta] EU/1/08/469/013 [60 tableta] EU/1/08/469/014 [90 tableta] EU/1/08/469/015 [100 tableta]
English: Oprymea 2.62 mg prolonged-release tablets 10 prolonged-release tablets: EU/1/08/469/046 30 prolonged-release tablets: EU/1/08/469/047 90 prolonged-release tablets: EU/1/08/469/048 100 prolonged-release tablets: EU/1/08/469/049
Croatian: Oprymea 2,62 mg tablete s produljenim oslobađanjem 10 tableta s produljenim oslobađanjem: EU/1/08/469/046 30 tableta s produljenim oslobađanjem: EU/1/08/469/047 90 tableta s produljenim oslobađanjem: EU/1/08/469/048 100 tableta s produljenim oslobađanjem: EU/1/08/469/049